Morioka Shinichiro

モリオカシンイチロウ | Morioka Shinichiro

Affiliation and department：
Job title： Deputy Chief Medical Director
Research theme for competitive and other funds (1)：

2022 - 2025 国内COVID-19入院患者のCOVID-19後遺症と生活習慣の関連の縦断研究

Papers (91)：

Shinichiro Morioka, Mio Nikaido, Shinya Tsuzuki, Satoshi Kutsuna, Sho Saito, Kayoko Hayakawa, Masaya Sugiyama, Norio Ohmagari. Retraction notice to < Epidemiology of post-COVID conditions beyond 3 years and factors associated with their persistence longer than 2 years: A cross-sectional study> <[Journal of Infection and Chemotherapy 30 (2024) 734-740]>. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy. 2024
Shinichiro Morioka, Shinya Tsuzuki, Yoshiaki Gu, Yumiko Fujitomo, Hiroshi Soeda, Chikara Nakahama, Naoki Hasegawa, Shigefumi Maesaki, Masayuki Maeda, Tetsuya Matsumoto, et al. Factors associated with the change of antimicrobial prescription before and after the National Action Plan on Antimicrobial Resistance: Additional analysis of a nationwide survey conducted by the Japanese Society of Chemotherapy and the Japanese Association for Infectious Diseases. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy. 2024
Taketomo Maruki, Shinichiro Morioka, Yusuke Miyazato, Shinya Tsuzuki, Kentaro Takezawa, Sohei Kuribayashi, Satoshi Kutsuna, Norio Ohmagari, Shinichiro Fukuhara. Association between post-COVID-19 conditions and male semen quality in Japan: A descriptive investigation. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy. 2024
松下由実, 横山徹爾, 齋藤翔, 早川佳代子, 松永展明, 寺田麻里, 鈴木節子, 森岡慎一郎, 忽那賢志, 原久男, et al. 体格とCOVID-19の重症化リスク非オミクロン株・オミクロン株期別解析. 糖尿病. 2024. 67. Suppl.1. S-216
Shinichiro Morioka, Mio Nikaido, Shinya Tsuzuki, Satoshi Kutsuna, Sho Saito, Kayoko Hayakawa, Masaya Sugiyama, Norio Ohmagari. Epidemiology of post-COVID conditions beyond 3 years and factors associated with their persistence longer than 2 years: A cross-sectional study. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy. 2024

ｍore...

MISC (94)：

森岡慎一郎. 新型コロナウイルス感染症の後遺症. 沖縄県医師会報. 2022. 58. 8-9. 408-409
Ide Satoshi, Morioka Shinichiro, Sugai Kazunori, Kimura Akio, Kajio Yutaka, Ohmagari Norio, Sugiyama Haruhito. Experience in dealing with COVID-19 pandemic with original phasing in our hospital. Japanese Journal of Disaster Medicine. 2022. 27. 2. 151-158
柏木征三郎, 大曲貴夫, 森岡慎一郎. 新型コロナウイルス感染症の臨床と後遺症. インフルエンザ. 2022. 23. 2. 99-106
森岡慎一郎. 新型コロナウイルス感染症の後遺症その後の動向. インフルエンザ. 2022. 23. 2. 125-130
森岡慎一郎. 緩和医療における感染症治療の位置づけ終末期がん患者における感染症疫学と抗菌薬治療、現場で悩むこと. Palliative Care Research. 2022. 17. Suppl. S.113-S.113

ｍore...

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page